BEVACIZUMAB

UNII:	2S9ZZM9Q9V
Formula:
Preferred Substance Name:	BEVACIZUMAB

216974-75-3
12-IGG1
ABP-215
ALYMSYS
AVA-1
AVASTIN
AVZIVI
BAT 1706 [WHO-DD]
BAT1706
BAT-1706
BAT-1706 (BIOSIMILAR OF BEVACIZUMAB)
BEVACIZUMAB (AVASTIN)
BEVACIZUMAB [EMA EPAR]
BEVACIZUMAB [INN]
BEVACIZUMAB [JAN]
BEVACIZUMAB [MART.]
BEVACIZUMAB [MI]
BEVACIZUMAB [PURPLE BOOK CDER]
BEVACIZUMAB [USAN]
BEVACIZUMAB [VANDF]
BEVACIZUMAB [WHO-DD]
BEVACIZUMAB AWWB [WHO-DD]
BEVACIZUMAB BETA
BEVACIZUMAB BETA [INN]
BEVACIZUMAB BETA [WHO-DD]
BEVACIZUMAB BIOSIMILAR - SHANGHAI HENLIUS BIOTECH
BEVACIZUMAB BIOSIMILAR (ABP-215)
BEVACIZUMAB BIOSIMILAR (AMGEN)
BEVACIZUMAB BIOSIMILAR (AMNEAL PHARMACEUTICALS)
BEVACIZUMAB BIOSIMILAR (CT-P16)
BEVACIZUMAB BIOSIMILAR (FKB-238)
BEVACIZUMAB BIOSIMILAR (GP-2019)
BEVACIZUMAB BIOSIMILAR (MABXIENCE)
BEVACIZUMAB BIOSIMILAR (PF-06439535)
BEVACIZUMAB BIOSIMILAR (PFIZER)
BEVACIZUMAB BIOSIMILAR-INNOVENT BIOLOGICS
BEVACIZUMAB BVZR [WHO-DD]
BEVACIZUMAB MALY [WHO-DD]
BEVACIZUMAB, LICENSE HOLDER UNSPECIFIED
BEVACIZUMAB-ADCD
BEVACIZUMAB-AWWB
BEVACIZUMAB-AWWB [PURPLE BOOK CDER]
BEVACIZUMAB-BVZR
BEVACIZUMAB-MALY
BEVACIZUMAB-NWGD
BEVACIZUMAB-TNJN
BEVAX
BEVZ92
BEVZ-92
BI 695502 [WHO-DD]
BI695502
BI-695502
BS-503
BS-503A
BYVASDA
CT16
CT-16
CTP16
CTP-16
CT-P16
CT-P16 (BIOSIMILAR OF BEVACIZUMAB)
FKB 238 [WHO-DD]
FKB238
FKB-238
GP2019
GP-2019
HLX 04 [WHO-DD]
HLX04
HLX-04
HLX04-O
HLX04-O (RECOMBINANT ANTI-VEGF HUMANIZED MONOCLONAL ANTIBODY OPHTHALMIC INJECTION)
IBI305
IBI-305
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF .GAMMA.-CHAIN ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF LIGHT CHAIN, DIMER
JOBEVNE
LY 01008
LY 01008 [WHO-DD]
LY 01008(BIOSIMILAR OF BEVACIZUMAB)
LY-01008
MB02
MB-02
MVASI
OYAVAS
PF-06439535
PF-06439535 [WHO-DD]
Q1101
Q-1101
QL-1101 (BIOSIMILAR OF BEVACIZUMAB)
RG-435
RHUMAB-
RO-4876646
USP MAB 002, MONOCLONAL IGG1 [USP-RS]
VEGZELMA
ZIRABEV

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BEVACIZUMAB

Synonyms and Mappings

Resources